Replies to post #114366 on Biotech Values

[oc631]

maybe a direct buyout is unrealistic but another company friendly(loyal) to TEVA could

Friendship and loyalty mean nothing in this cutthroat business. Look no further than Sandoz's pipeline of FOB.

TEVA could even try to "bribe" its way in by offering to partner (and fund) other drugs with MNTA ( unlikely,unethical but not impossible),back door deal with another pharma to take out MNTA in buyout and slow down MCopax and in return TEVA could slow down on their own competing generics from that Pharama (again unethical,illegal but not impossible)

billions at stake,anything is possible

These examples would make a mockery of the DOJ's antitrust division and IMO are impossible.